Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Clinical Study to Assess the Impact of Quell Technology on Opioid Use and Pain

June 28, 2016 By NeuroMetrix, Inc.

NeuroMetrix, Inc. and the Scripps Translational Science Institute (STSI) will host a clinical study of Quell wearable pain relief technology in patients with cancer related pain.

According to the National Cancer Institute, about 15 million Americans are living with cancer or have a history of cancer. In these patients, chronic pain is one of the most feared and challenging symptoms. Unfortunately, the prevalence of pain is over 50 percent in most forms of cancer.

Prescription opioids are the mainstay of the medical management of moderate to severe cancer pain. However, given the side effects and the stigma of opioid use, there is growing interest in alternative approaches to managing cancer related pain.

Quell utilizes neurostimulation technology to provide relief from chronic pain. The wearable device is lightweight and can be worn during the day while active, and at night while sleeping. In addition to analgesic therapy, Quell objectively tracks utilization and various health metrics including sleep and activity.

(Credit: Associated Press)

In a recent study of Quell in non-cancer chronic pain, 81 percent of participants reported improvement in their chronic pain on the Patient Global Impression of Change (PGIC) scale. In addition, 67 percent of participants reported a reduction in use of analgesics.

The STSI study is 10-week single site, double blinded, sham controlled randomized clinical trial. The study will enroll 40 adult patients who have been diagnosed with metastatic breast, prostate or colorectal cancer and who use at least one opioid medication on a daily basis.

The patients will be recruited from the Scripps Cancer Center in Hillcrest, which serves central San Diego and is a cornerstone fellowship and research site for both palliative care and oncology. The primary endpoint is a reduction in daily opioid use assessed at weeks 2, 4, 6, 8 and 10 of the study.

A 20 percent change in opioid consumption will be deemed clinically relevant. That primary end point was chosen to provide a novel way for patients with cancer to have optimal pain control while reducing their overall opioid use.

The study will also examine the potential benefits of Quell as a digital health intervention. The device integrates with a smartphone app that includes electronic pain tracking and provides objective feedback to the subject about their therapy utilization and sleep.

Earlier this month, NeuroMetrix submitted a CE technical file application for the Quell pain management device seeking certification in the European Union as a class IIa medical device.

Related Articles Read More >

Myoshirt creator Marie Georgarakis wearing her device, which has cufs on her arm supported by a cable connected to equipment on her shoulder.
Researchers develop wearable robotic exomuscle system
A woman wearing a hearing aid
Why filter bank design is critical for effective hearing aids
Northwestern University dissolvable pacemaker
This smart, dissolving pacemaker communicates with sensors on the body for remote patient monitoring
Outcome-Based Technologies' Excyabir CryoKnee
DJO’s Enovis buys orthopedic bracing assets of Outcome-Based Technologies

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech